Ortho-McNeil Neurologics has announced that it is changing the appearance of Topamax (topiramate) Tablets to help reduce medication errors involving Toprol XL (metoprolol succinate extended-release tablets, from AstraZeneca). The color of Topamax 25mg tablets will be changed from white to cream. The imprint code for all tablet strengths will be changed from “TOP” or “TOPAMAX” to “OMN”. There is no change in appearance to Topamax Sprinkle Capsules. In addition, the NDC numbers for both Topamax Tablets and Sprinkle Capsules are changing.
Topamax is indicated for treatment of partial-onset or primary generalized tonic-clonic seizures, as adjunctive therapy in Lennox-Gastaut syndrome, and for migraine prophylaxis.
For more information call (800) 526-7736 or visit www.omjsamedicalinformation.com.